Metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya
Open Access
- 1 August 2008
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 14 (8), 755-759
- https://doi.org/10.1111/j.1469-0691.2008.02030.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Metallo beta lactamases inPseudomonas aeruginosaand Acinetobacter speciesExpert Opinion on Investigational Drugs, 2008
- Long-term evolution of a nosocomial outbreak of Pseudomonas aeruginosa producing VIM-2 metallo-enzymeJournal of Hospital Infection, 2008
- Carbapenemases: Molecular Diversity and Clinical ConsequencesFuture Microbiology, 2007
- Molecular Epidemiology of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa in the Calgary Health Region: Emergence of VIM-2-Producing IsolatesJournal of Clinical Microbiology, 2007
- The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter SpeciesClinical Infectious Diseases, 2006
- Population‐Based Epidemiological Study of Infections Caused by Carbapenem‐ResistantPseudomonas aeruginosain the Calgary Health Region: Importance of Metallo‐β‐Lactamase (MBL)–Producing StrainsThe Journal of Infectious Diseases, 2005
- Detection of Pseudomonas aeruginosa Producing Metallo-β-Lactamases in a Large Centralized LaboratoryJournal of Clinical Microbiology, 2005
- Metallo-β-Lactamases: the Quiet before the Storm?Clinical Microbiology Reviews, 2005
- Emerging carbapenemases in Gram-negative aerobesClinical Microbiology & Infection, 2002
- Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in FranceAntimicrobial Agents and Chemotherapy, 2000